Form DEFA14A MIMEDX GROUP, INC.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
(Rule 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the registrant ☒ | Filed by a party other than the registrant ☐ | ||||||||||
Check the appropriate box:
☐ | Preliminary Proxy Statement | ||||||||||
☐ | Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) | ||||||||||
☐ | Definitive Proxy Statement | ||||||||||
☒ | Definitive Additional Materials | ||||||||||
☐ | Soliciting Material Pursuant to §240.14a-12 | ||||||||||
MIMEDX GROUP, INC.
(Name of registrant as specified in its charter)
Payment of the filing fee (check the appropriate box):
☒ | No fee required. | ||||||||||
☐ | Fee paid previously with preliminary materials. | ||||||||||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11 | ||||||||||
1
2
3
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
- Military Metals Files Appeal with Government Regarding Decision on Trojarova Antimony License, Europe
- Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
